IT8047580A0 - Derivati di 1,2-diidro-2-osso-4-fe nil-3-chinolin-carbonitrile dotati di proprieta' anti-infiammatorie - Google Patents
Derivati di 1,2-diidro-2-osso-4-fe nil-3-chinolin-carbonitrile dotati di proprieta' anti-infiammatorieInfo
- Publication number
- IT8047580A0 IT8047580A0 IT8047580A IT4758080A IT8047580A0 IT 8047580 A0 IT8047580 A0 IT 8047580A0 IT 8047580 A IT8047580 A IT 8047580A IT 4758080 A IT4758080 A IT 4758080A IT 8047580 A0 IT8047580 A0 IT 8047580A0
- Authority
- IT
- Italy
- Prior art keywords
- quinolin
- carbonitrile
- nil
- dihydro
- oxo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D281/02—Seven-membered rings
- C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/007,069 US4232027A (en) | 1979-01-29 | 1979-01-29 | 1,2-Dihydro-2-oxo-4-phenyl-3-quinolinecarbonitrile derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IT8047580A0 true IT8047580A0 (it) | 1980-01-11 |
| IT1145403B IT1145403B (it) | 1986-11-05 |
Family
ID=21724050
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT8047580A IT1145403B (it) | 1979-01-29 | 1980-01-11 | Derivati di 1,2-diidro-2-osso-4-fenil-3-chinolin-carbonitrile dotati di proprieta' anti-infiammatorie |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US4232027A (it) |
| JP (1) | JPS55102568A (it) |
| DE (1) | DE3003146A1 (it) |
| FR (1) | FR2447376A1 (it) |
| GB (1) | GB2041361B (it) |
| IT (1) | IT1145403B (it) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0024638A1 (en) * | 1979-08-30 | 1981-03-11 | Byk Gulden Lomberg Chemische Fabrik GmbH | Substituted quinolinone-alkanecarboxylic acids, their preparation, and medicaments containing them |
| JPH03181465A (ja) * | 1989-12-11 | 1991-08-07 | Takeda Chem Ind Ltd | キノリン誘導体 |
| AU1860995A (en) * | 1994-03-08 | 1995-09-25 | Takeda Chemical Industries Ltd. | Quinoline or quinazoline derivatives as anti-inflammatory agents, in particular for treating arthritis |
| CA2539760C (en) * | 2003-09-23 | 2011-01-25 | Merck & Co., Inc. | Quinoline potassium channel inhibitors |
| CR20190338A (es) | 2016-12-22 | 2019-09-09 | Amgen Inc | Inhibidores de kras g12c y métodos para su uso |
| UA127968C2 (uk) | 2017-05-22 | 2024-02-28 | Емджен Інк. | Інгібітори g12c kras і способи їх застосування |
| US10640504B2 (en) | 2017-09-08 | 2020-05-05 | Amgen Inc. | Inhibitors of KRAS G12C and methods of using the same |
| MX2020010836A (es) | 2018-05-04 | 2021-01-08 | Amgen Inc | Inhibidores de kras g12c y métodos para su uso. |
| EP3788053B1 (en) | 2018-05-04 | 2024-07-10 | Amgen Inc. | Kras g12c inhibitors and methods of using the same |
| WO2019217691A1 (en) | 2018-05-10 | 2019-11-14 | Amgen Inc. | Kras g12c inhibitors for the treatment of cancer |
| WO2019232419A1 (en) | 2018-06-01 | 2019-12-05 | Amgen Inc. | Kras g12c inhibitors and methods of using the same |
| AU2019284472B2 (en) | 2018-06-11 | 2024-05-30 | Amgen Inc. | KRAS G12C inhibitors for treating cancer |
| JP7369719B2 (ja) | 2018-06-12 | 2023-10-26 | アムジエン・インコーポレーテツド | ＫＲａｓ Ｇ１２Ｃ阻害剤及びそれを使用する方法 |
| JP7516029B2 (ja) | 2018-11-16 | 2024-07-16 | アムジエン・インコーポレーテツド | Ｋｒａｓ ｇ１２ｃ阻害剤化合物の重要な中間体の改良合成法 |
| JP7377679B2 (ja) | 2018-11-19 | 2023-11-10 | アムジエン・インコーポレーテツド | がん治療のためのｋｒａｓｇ１２ｃ阻害剤及び１種以上の薬学的に活性な追加の薬剤を含む併用療法 |
| JP7454572B2 (ja) | 2018-11-19 | 2024-03-22 | アムジエン・インコーポレーテツド | Ｋｒａｓ ｇ１２ｃ阻害剤及びその使用方法 |
| EP3738593A1 (en) | 2019-05-14 | 2020-11-18 | Amgen, Inc | Dosing of kras inhibitor for treatment of cancers |
| EP3972973A1 (en) | 2019-05-21 | 2022-03-30 | Amgen Inc. | Solid state forms |
| US20240190842A1 (en) * | 2022-11-09 | 2024-06-13 | Accutar Biotechnology Inc. | Substituted quinolinone-8-carbonitrile derivatives having androgen degradation activity and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3210358A (en) * | 1961-08-09 | 1965-10-05 | Geigy Chem Corp | Substituted 4-amino carbostyrils |
| CH471784A (de) * | 1966-01-26 | 1969-04-30 | Bayer Ag | Verfahren zur Herstellung von Carbostyrilderivaten |
| US3763153A (en) * | 1972-02-22 | 1973-10-02 | Squibb & Sons Inc | Benzothiazines |
| US3895006A (en) * | 1974-04-19 | 1975-07-15 | Squibb & Sons Inc | 5-(Substituted amino)alkyl)-2-aryl-3-halo-1,5-benzothiazepin-4(5H)-ones |
| US3994900A (en) * | 1976-01-23 | 1976-11-30 | E. R. Squibb & Sons, Inc. | 6-(Or 8)-[[(substituted amino)alkyl]oxy(or thio)]-3,4-dihydro-4-phenyl-2(1H)-quinolinones |
-
1979
- 1979-01-29 US US06/007,069 patent/US4232027A/en not_active Expired - Lifetime
-
1980
- 1980-01-03 GB GB8000160A patent/GB2041361B/en not_active Expired
- 1980-01-11 IT IT8047580A patent/IT1145403B/it active
- 1980-01-28 JP JP923380A patent/JPS55102568A/ja active Pending
- 1980-01-29 FR FR8001874A patent/FR2447376A1/fr not_active Withdrawn
- 1980-01-29 DE DE19803003146 patent/DE3003146A1/de not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| JPS55102568A (en) | 1980-08-05 |
| GB2041361A (en) | 1980-09-10 |
| US4232027A (en) | 1980-11-04 |
| DE3003146A1 (de) | 1980-08-07 |
| IT1145403B (it) | 1986-11-05 |
| GB2041361B (en) | 1982-12-08 |
| FR2447376A1 (fr) | 1980-08-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IT1116820B (it) | Derivati di moranolina con proprieta'farmacologiche | |
| IT8025206A0 (it) | Derivati di 4-fenil-ftalazine ad azione terapeutica. | |
| IT7919908A0 (it) | Derivati di alchilendiamine. | |
| IT8048000A0 (it) | Composti eterociclici dotati di pro prieta' farmacologiche e procedimento per la loro preparazione | |
| IT1141057B (it) | Derivati di deformiltilosina e loro preparazione | |
| IT1145403B (it) | Derivati di 1,2-diidro-2-osso-4-fenil-3-chinolin-carbonitrile dotati di proprieta' anti-infiammatorie | |
| IT8024713A0 (it) | Nuovi derivati del beta -3-ammino-nortropano. | |
| IT8022265A0 (it) | Derivati di alchil-chetoesopiranosidi. | |
| IT1209143B (it) | Derivati di 7-osso-4-tia-1-aza-biciclo-[3,2,0]eptano | |
| IT8047529A0 (it) | Derivati di acido epossisuccinico dotati di proprieta' farmacologiche | |
| IT1143671B (it) | Procedimento per la fabbricazione di triptofano e di suoi derivati | |
| RO82507A (ro) | Procedeu pentru prepararea unor derivati ai acidului 1,2,3-tiadiazol-procedeu pentru prepararea unor derivati ai acidului 1,2,3-tiadiazol-5-carboxilic | |
| IT7948449A0 (it) | Derivati di 3,3-dicloro-2-azetidino ne ad attivita' anti-infiammatoria | |
| IT8024150A0 (it) | Derivati di alovincamone eprocedimento per la loro preparazione. | |
| IT1164906B (it) | Derivati indolici dotati di proprieta' farmacologiche | |
| IT1122391B (it) | Derivati di idrochinone e relativo procedimento per la loro produzione | |
| IT7825800A0 (it) | Procedimento per la fabbricazione di p-idrossifenilglicina e suoi derivati | |
| IT1085538B (it) | Derivati di i 125 immidazol-steroidi | |
| IT7950202A0 (it) | Derivati alfa-aril-alfa alfa-bisomega-ammino bisostituiti alchilacetammidici ditati di proprieta'farmacologiche antiaritmia | |
| IT8024151A0 (it) | Derivati di 10-alo-e-omoeburnano eprocedimento per la loro preparazione. | |
| IT1116869B (it) | Derivati di n-alcheni-moranolina aventi attivita'farmacologica | |
| IT1162702B (it) | Derivati di 11-alcanoil-4"-isonitril-oleandomicina | |
| IT8020503A0 (it) | Derivati della 1,1'-bifenil-2-ilalchilammina ad azione farmaceutica. | |
| IT1196401B (it) | Derivati acil-1h-1,2,4-triazolici | |
| IT7922447A0 (it) | Derivati di n-ciano-azometini. |